Manager × security

Rhenman & Partners Asset Management AB ELV holdings history

Who else holds this security? →

ELEVANCE HEALTH INC · CUSIP 036752103 · CIK 1599882

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Rhenman & Partners Asset Management AB reported 34.90K ELV (shares), valued at $13.50M, or 1.27% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.27%
Shares
34.90K
34,900
Reported value
$13.50M
USD

Shares increased 8.05%; reported value increased 42.74%, and weight changed +0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.27%34,900SEC filing ↗Filed Aug 13, 2026
Q1 20261.17%32,300SEC filing ↗Filed May 14, 2026
Q4 20250.49%15,000SEC filing ↗Filed Feb 13, 2026
Q3 20250.80%22,500SEC filing ↗Filed Nov 13, 2025
Q2 20252.20%44,650SEC filing ↗Filed Aug 13, 2025
Q1 20252.45%48,950SEC filing ↗Filed May 14, 2025
Q4 20240.88%23,150SEC filing ↗Filed Feb 13, 2025
Q3 20242.13%50,500SEC filing ↗Filed Nov 13, 2024
Q2 20244.46%85,800SEC filing ↗Filed Aug 13, 2024
Q1 20243.42%69,500SEC filing ↗Filed May 14, 2024
Q4 20230.61%13,000SEC filing ↗Filed Feb 13, 2024
Q3 20231.78%38,000SEC filing ↗Filed Nov 13, 2023Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20231.78%38,000$16.55MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 13, 2023
Q4 20230.61%13,000$6.13MShares decreased 65.79%; reported value decreased 62.95%, and weight changed -1.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2024
Q1 20243.42%69,500$36.04MShares increased 434.62%; reported value increased 487.88%, and weight changed +2.81 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20244.46%85,800$46.49MShares increased 23.45%; reported value increased 29.01%, and weight changed +1.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 20242.13%50,500$26.26MShares decreased 41.14%; reported value decreased 43.52%, and weight changed -2.33 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2024
Q4 20240.88%23,150$8.54MShares decreased 54.16%; reported value decreased 67.48%, and weight changed -1.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2025
Q1 20252.45%48,950$21.29MShares increased 111.45%; reported value increased 149.31%, and weight changed +1.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 20252.20%44,650$17.37MShares decreased 8.78%; reported value decreased 18.43%, and weight changed -0.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2025
Q3 20250.80%22,500$7.27MShares decreased 49.61%; reported value decreased 58.14%, and weight changed -1.40 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20250.49%15,000$5.26MShares decreased 33.33%; reported value decreased 27.67%, and weight changed -0.31 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 20261.17%32,300$9.46MShares increased 115.33%; reported value increased 79.83%, and weight changed +0.68 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2026
Q2 20261.27%34,900$13.50MShares increased 8.05%; reported value increased 42.74%, and weight changed +0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2026
Rhenman & Partners Asset Management AB · ELEVANCE HEALTH INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1599882","quarter":"2026Q2","cusip":"036752103"}

get_institutional_manager_history
{"cik":"1599882","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.